November 23, 2011 – Vascular occlusions are blocked blood vessels caused by a blood clot in an artery. Blocks in the femoral artery are particularly problematic, and vascular surgeons continue to research and debate on the best methods to treat these clots. Results from the THRUPASS Study Group’s randomized controlled trial comparing superficial femoral artery (SFA) lesion treatment with either endoluminal polytetrafluoroethylene (PTFE) thrupass (Viabahn) or with surgical PTFE bypass were presented to attendees at the 38th Annual VEITH symposium in New York City by Mauri J.A. Lepantalo, M.D., Helsinki University Central Hospital, Helsinki, Finland.


Over the last 10 years, hospitals have phased out analog image intensifiers for flat-panel, digital detector angiography systems in their cath labs. As hospitals look to purchase current-generation digital angiography systems, buyers should be aware of several new technologies.

We are at an inflection point with many aspects of medicine, not the least of which concerns choosing the correct tool to discover and manage coronary artery disease. The American landscape of clinical and imaging service providers is going through a major reshuffle. Coronary computed tomography angiography (CTA) is growing in utilization, taking its place as an established modality with AHA-, ACC- and ACR society-derived appropriate use standards. However, this growth in CT utilization and the resultant growth in per capita radiation exposure have elevated a very public debate about the risk of causing cancer versus the value of its information content.

November 23, 2011 – Many specialists question whether a permanent inferior vena cava (IVC) filter can be developed where it does not have to be retrieved from the patient.

November 23, 2011 – Medical technology incubator Therix Medical announced the launch of spin-off Bluegrass Vascular Technologies, the flagship product of which is the Surfacer Inside-Out Access catheter system, a proprietary instrumentation set that allows physicians to perform a novel “inside-out” approach to gain venous access.

November 23 2011 – At the 2011 VEITH symposium, Arno von Ristow, M.D., department of vascular and endovascular surgery, Centervasc-Rio & Clinica Sorocaba, Catholic University of Rio de Janeiro, Brazil, presented some strong findings regarding the use of endovascular techniques to deal with the management of para-anastomotic aneurysms.

 

November 23, 2011 – The U.S. Food and Drug Administration (FDA) allowed marketing of the first system that can repair a failed or problematic aortic endograft, a fabric tube used to repair a dangerously large aortic aneurysm, a bulge in the large blood vessel that carries blood away from the heart.

 
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now